Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug

Middle East Respiratory Syndrome (MERS) is a respiratory disease caused by a coronavirus (MERS-CoV). Since its emergence in 2012, nosocomial amplifications have led to its high epidemic potential and mortality rate of 34.5%. To date, there is an unmet need for vaccines and specific therapeutics for...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Hanjie Jonathan, Harikishore, Amaravadhi, Lee, Jihye, Jeon, Sangeun, Rajan, Sreekanth, Chen, Ming Wei, Neo, Jun Long, Kim, Seungtaek, Yoon, Ho Sup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726485/
https://www.ncbi.nlm.nih.gov/pubmed/33309540
http://dx.doi.org/10.1016/j.antiviral.2020.104996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726485/
https://www.ncbi.nlm.nih.gov/pubmed/33309540
http://dx.doi.org/10.1016/j.antiviral.2020.104996

Ejemplares similares